PT  - JOURNAL ARTICLE
AU  - Parry, Nicola
ED  - Després, Jean-Pierre
TI  - Update on Dyslipidemia and Cardiovascular Disease
DP  - 2013 Nov 01
TA  - MD Conference Express
PG  - 27--29
VI  - 13
IP  - 15
4099  - http://mdc.sagepub.com/content/13/15/27.short
4100  - http://mdc.sagepub.com/content/13/15/27.full
AB  - Despite the use of statins in patients who are dyslipidemic, residual risk of cardiovascular disease remains increased in many individuals [Libby P. J Am Coll Cardiol 2005]. New therapies are therefore needed to enhance the current standard of care for patients with high cardiometabolic risk [Chapman MJ et al. Eur Heart J 2009]. Key opinion leaders discussed the role of other available options for elevating high-density lipoprotein cholesterol.